Real-world genomic testing and treatment patterns of newly diagnosed adult acute myeloid leukemia patients within a comprehensive health system.

John C ByrdJennifer L GatzCynthia Lim LouisAlice S MimsUma BorateAshley O YocumTheophilus J GanaAmy Burd

Published in: Cancer medicine (2023)

Our results highlight the unmet medical need to increase access to genomic testing to afford treatment options, particularly to older AML patients in the real-world setting, in this new era of targeted therapies.

Keyphrases

newly diagnosed
acute myeloid leukemia
end stage renal disease
ejection fraction
chronic kidney disease
gene expression
physical activity
patient reported outcomes
copy number
allogeneic hematopoietic stem cell transplantation
acute lymphoblastic leukemia